688131 皓元醫藥
按盤價 
93.580 -2.690 (-2.794%) | 2026/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 1,647,974 | 25.71% | 2,876,896 | 2,270,178 | 1,880,047 | 1,358,054 | |
| 減：營業總成本 | 1,384,319 | 27.73% | 2,442,469 | 1,900,882 | 1,672,707 | 1,144,721 | |
| 其中:營業成本 | 811,401 | 21.53% | 1,521,776 | 1,181,279 | 1,030,874 | 659,411 | |
| 財務費用 | 69,968 | 319.24% | 63,034 | 34,516 | 31,850 | (578) | |
| 資產減值損失 | (79,887) | 31.03% | (134,088) | (131,360) | (83,999) | (43,376) | |
| 公允價值變動收益 | 283 | 33.00% | 74 | 150 | -- | -- | |
| 投資收益 | 311 | -75.06% | (15,967) | (13,758) | (4,772) | 16,053 | |
| 其中：對聯營企業和合營企業的投資收益 | (2,534) | -37.18% | (8,514) | (13,771) | (6,113) | (2,746) | |
| 營業利潤 | 193,528 | 4.77% | 296,753 | 236,817 | 128,329 | 196,567 | |
| 利潤總額 | 192,593 | 6.04% | 275,776 | 238,355 | 128,193 | 198,543 | |
| 減：所得稅費用 | 30,497 | -7.38% | 44,130 | 40,425 | 1,885 | 6,986 | |
| 淨利潤 | 162,096 | 9.01% | 231,645 | 197,930 | 126,308 | 191,558 | |
| 減：非控股權益 | (9,104) | 197.03% | (8,161) | (3,660) | (1,142) | (2,086) | |
| 股東淨利潤 | 171,200 | 12.81% | 239,807 | 201,590 | 127,449 | 193,643 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.810 | 12.50% | 1.130 | 0.960 | 0.610 | 1.330 | |
| 每股派息 (元) * | 0.090 | 12.50% | 0.230 | 0.190 | 0.150 | 0.380 | |
| 每股淨資產 (元) * | 15.102 | 8.76% | 14.343 | 13.109 | 16.684 | 21.690 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 28/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
